The tariff classification of Ethacrynate Sodium Injection and Mycophenolate Mofetil Injection in dosage form, from India
Reasoning
The tariff classification of Ethacrynate Sodium Injection and Mycophenolate Mofetil Injection in dosage form, from India
Cite this ruling
CBP Ruling N288839 (3004909215): The tariff classification of Ethacrynate Sodium Injection and Mycophenolate Mofetil Injection in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
Protest 1101-00-100042; ZD 1839 tablets
The tariff classification of Abacavir Sulfate (CAS-188062-50-2), imported in bulk form, and Ziagen™ (abacavir sulfate) tablets and Ziagen™ (abacavir sulfate) Oral Solution, from various countries, including the United Kingdom, France, Italy, Canada, and Singapore
The tariff classification of Naratriptan Hydrochloride (CAS-143388-64-1), imported in bulk form, and AMERGE® (naratriptan hydrochloride) tablets, from various countries, including the United Kingdom, France, Italy, Canada, and Singapore
The tariff classification of Zanamivir (CAS-139110-80-8), imported in bulk form, and RELENZA® (zanamivir for inhalation), from the United Kingdom, France, Italy, Canada, Singapore, etc.
Protest 4909-99-100036; Prucalopride succinate tablets